What is the address of Dr. Delphine Gryson Pediater?

The registered office of Dr. Delphine Gryson Pediater is located at Astridlaan 490, 8310 Brugge.

Is Dr. Delphine Gryson Pediater still active?

Yes. According to the CBE (3 October 2026) Dr. Delphine Gryson Pediater is active, legal situation “Normale toestand”, started on 18 September 2020.

Is Dr. Delphine Gryson Pediater registered on Peppol?

Yes, Dr. Delphine Gryson Pediater is registered on the Peppol network with ID 0208:0754607639.

What is the enterprise number of Dr. Delphine Gryson Pediater?

The enterprise number of Dr. Delphine Gryson Pediater is BE0754607639.

When was Dr. Delphine Gryson Pediater founded?

Dr. Delphine Gryson Pediater was founded on 18 September 2020.

Who are the directors of Dr. Delphine Gryson Pediater?

According to the 2025 annual accounts, the directors of Dr. Delphine Gryson Pediater are: Delphine Gryson.

Is Dr. Delphine Gryson Pediater a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 September 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Delphine Gryson Pediater make in 2025?

Dr. Delphine Gryson Pediater posted a profit after taxes of € 82,216 in financial year 2025.

What is the revenue of Dr. Delphine Gryson Pediater?

As a small company, Dr. Delphine Gryson Pediater is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 132,427.

Dr. Delphine Gryson Pediater (Private Limited) - Brugge

Dossier Dr. Delphine Gryson Pediater, printed on 3 October 2026 from databakkes.be/en/0754607639/dr-delphine-gryson-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Delphine Gryson Pediater from Brugge, company number BE0754607639, closed financial year 2025 with a result of € 82,216 after tax. For that financial year Dr. Delphine Gryson Pediater recorded a gross margin of € 132,427 and equity of € 98,908. Compared with financial year 2024, the result moved from € 75,362 to € 82,216. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Healthy

€ 98,908

▼ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 82,216

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 268,700

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 47,142

▲ € 45,888 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,013

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,076

▲ 62% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 98,774 Gross margin 2022: € 98,774 First fiscal year in the series	€ 115,659 Gross margin 2023: € 115,659 ▲ 17% vs 2022 (€ 98,774) Favourable step	€ 100,762 Gross margin 2024: € 100,762 ▼ 13% vs 2023 (€ 115,659) Unfavourable step	€ 132,427 Gross margin 2025: € 132,427 ▲ 31% vs 2024 (€ 100,762) Favourable step	▲ 31%
Profit after taxes	€ 76,161 Profit after taxes 2022: € 76,161 First fiscal year in the series	€ 89,120 Profit after taxes 2023: € 89,120 ▲ 17% vs 2022 (€ 76,161) Favourable step	€ 75,362 Profit after taxes 2024: € 75,362 ▼ 15% vs 2023 (€ 89,120) Unfavourable step	€ 82,216 Profit after taxes 2025: € 82,216 ▲ 9% vs 2024 (€ 75,362) Favourable step	▲ 9%
Equity	€ 252,211 Equity 2022: € 252,211 First fiscal year in the series	€ 341,331 Equity 2023: € 341,331 ▲ 35% vs 2022 (€ 252,211) Favourable step	€ 166,693 Equity 2024: € 166,693 ▼ 51% vs 2023 (€ 341,331) Unfavourable step	€ 98,908 Equity 2025: € 98,908 ▼ 41% vs 2024 (€ 166,693) Unfavourable step	▼ 41%
Total debts	€ 80,757 Total debts 2022: € 80,757 First fiscal year in the series	€ 50,832 Total debts 2023: € 50,832 ▼ 37% vs 2022 (€ 80,757) Favourable step	€ 192,737 Total debts 2024: € 192,737 ▲ 279% vs 2023 (€ 50,832) Unfavourable step	€ 291,255 Total debts 2025: € 291,255 ▲ 51% vs 2024 (€ 192,737) Unfavourable step	▲ 51%
Cash	€ 252,888 Cash 2022: € 252,888 First fiscal year in the series	€ 112,783 Cash 2023: € 112,783 ▼ 55% vs 2022 (€ 252,888) Unfavourable step	€ 180,149 Cash 2024: € 180,149 ▲ 60% vs 2023 (€ 112,783) Favourable step	€ 268,700 Cash 2025: € 268,700 ▲ 49% vs 2024 (€ 180,149) Favourable step	▲ 49%
Land & buildings	-	€ 7,211 Land & buildings 2023: € 7,211 First fiscal year in the series	€ 6,471 Land & buildings 2024: € 6,471 ▼ 10% vs 2023 (€ 7,211) Unchanged	€ 5,732 Land & buildings 2025: € 5,732 ▼ 11% vs 2024 (€ 6,471) Unchanged	▼ 11%
Retained profit	€ 249,211 Retained profit 2022: € 249,211 First fiscal year in the series	€ 338,331 Retained profit 2023: € 338,331 ▲ 36% vs 2022 (€ 249,211) Favourable step	€ 163,693 Retained profit 2024: € 163,693 ▼ 52% vs 2023 (€ 338,331) Unfavourable step	€ 95,908 Retained profit 2025: € 95,908 ▼ 41% vs 2024 (€ 163,693) Unfavourable step	▼ 41%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 800) Unchanged	€ 250,000 Dividend 2024: € 250,000 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▼ 40% vs 2024 (€ 250,000) Unchanged	▼ 40%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 3 Bank debt 2023: € 3 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 332,968 Balance sheet total 2022: € 332,968 First fiscal year in the series	€ 392,163 Balance sheet total 2023: € 392,163 ▲ 18% vs 2022 (€ 332,968) Unchanged	€ 359,430 Balance sheet total 2024: € 359,430 ▼ 8% vs 2023 (€ 392,163) Unchanged	€ 390,163 Balance sheet total 2025: € 390,163 ▲ 9% vs 2024 (€ 359,430) Unchanged	▲ 9%

Key figures of Dr. Delphine Gryson Pediater, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Delphine Gryson Pediater?

What happened at Dr. Delphine Gryson Pediater in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 82,216 (▲ 9% vs 2024). Source: NBB ↗
Sep 18, 2020 New establishment in Brugge. KBO
2020 Delphine Gryson became a director. NBB
Sep 18, 2020 Start of the company according to the CBE. KBO

In short

From € 76,161 profit in 2022 to € 82,216 profit in 2025.

Paid € 87,856 in corporate taxes since 2022.

Best year ever: 2023, with € 89,120 profit.

Paid out € 400,800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Delphine Gryson Pediater? We notify you, reason included.

Follow Dr. Delphine Gryson Pediater

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Delphine Gryson

Dr. Delphine Gryson Pediater

Behind Dr. Delphine Gryson Pediater is Delphine Gryson.

See the full network in the app

Directors

According to the 2025 annual accounts

Delphine Gryson

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Astridlaan 490

8310 Brugge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0754.607.639
VAT number: BE 0754.607.639
Registered office: Astridlaan 490, 8310 Brugge
Names & denominations: Dr. Delphine Gryson Pediater
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 September 2020
Peppol: Active · Active since 31 Oct 2023

View on CBE Public ↗ Annual accounts (NBB) ↗